Real Assets

Real Assets

We build future energy systems and resilient infrastructure, backing emerging opportunities in technology, land and water.

Latest news

News

Foresight invests £2.5 million into Bloemteknik

Latest news

News

Foresight invests £2.5 million into Bloemteknik

Featured insight

Insights

Are EVs really rolling backwards?

Skip to main content
Engagement case study

Siemens Healthineers

Q3 2024 Engagement case study: Product impact

Siemens Healthineers is a global medical technology company which was spun out of Siemens AG in 2017. Through four business segments, it specialises in the provision of diagnostic imaging, diagnostics, radiation oncology equipment and equipment for minimally invasive surgeries (MIS). All four segments help contribute towards either an improved quality of life and/or extending life expectancy for patients.


Objective: For Siemens Healthineers to publish data that helps to strengthen investors’ understanding of the positive impacts enabled through its products and services.

Background: We continually seek to further strengthen our understanding of the positive impact associated with the products and services sold by our investee companies. Additional insights allow us to build a stronger investment case and ‘impact story’ for each of our stocks. WHEB encourages investee companies to improve how they report on the positive sustainability impacts of their products and services. This helps other investors recognise these companies as having a strong impact, making it easier for them to direct capital toward these businesses.

Actions: The Investor Relations representative for Siemens Healthineers visited our offices. This gave us the opportunity to ask him for further information and data with regards to the positive impact of the company's Varian segment on patient outcomes. 

Progress/Outcomes:

M2 

Siemen’s Healthineers shared information regarding Varian's latest innovation, HyperSight. This technology offers significantly higher resolution imaging and drastically reduces image acquisition time from 60 seconds to just 6 seconds. This enables better visualization and faster workflow. Importantly, HyperSight allows real-time adaptation of treatment if the tumor or surrounding organs have shifted, avoiding delays and ensuring more effective, personalized therapy. This innovation improves clinical outcomes by offering superior accuracy and flexibility in treatment, benefiting patient care.

News & Insights

You have viewed 0 of 0

Important information


Foresight Group LLP does not offer legal, tax, financial or investment advice and the information on this website should not be construed as such. We recommend investors seek advice from a regulated financial adviser. The opportunity described in this document may not be suitable for all investors. Any such investment decision should be made only on the basis of the Fund scheme documents and appropriate professional advice.

Foresight Group LLP acts as investment manager and is authorised and regulated by the Financial Conduct Authority with Firm Reference Number 198020 and has its registered office at The Shard, 32 London Bridge Street, London SE1 9SG.

OEICs

An investment in FP Sustainable Future Themes Fund, FP Foresight Global Real Infrastructure Fund, FP Sustainable Real Estate Securities Fund, FP UK Infrastructure Income Fund or FP WHEB Sustainability Impact Fund and Liontrust Diversified Real Assets Fund (together the “Funds”) should be considered a long-term investment that may be higher risk. Portfolio holdings are subject to change without notice.

The Authorised Corporate Directors FundRock Partners Limited (registered office at Hamilton Centre, Rodney Way, Chelmsford, England, CM1 3BY) and Liontrust Investment Partners LLP (registered office 2 Savoy Court, London WC2R 0EZ), are authorised and regulated by the Financial Conduct Authority with Firm Reference Numbers 469278 and 518552 respectively. The Funds are incorporated in England and Wales.

ICAVs

An investment in the WHEB Sustainable Impact Fund and the WHEB Environmental Impact Fund (together the “Funds”) should be considered a longer-term investment that may be higher risk. Portfolio holdings are subject to change without notice.

The Manager of the Funds is FundRock Management Company S.A., authorised and regulated by the Luxembourg regulator to act as UCITS management company and has its registered office at Airport Center Building, 5, Heienhaff, L-1736 Senningerberg, Luxembourg.

We respect your privacy and are committed to protecting your personal data. If you would like to find out more about the measures, we take in processing your personal information, please refer to our privacy policy, which can be found at http://www.foresight.group/privacy-policy.